vs
MACOM Technology Solutions Holdings, Inc.（MTSI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
MACOM Technology Solutions Holdings, Inc.的季度营收约是Orthofix Medical Inc.的1.2倍（$271.6M vs $219.9M），MACOM Technology Solutions Holdings, Inc.净利率更高（18.0% vs -1.0%，领先19.0%），MACOM Technology Solutions Holdings, Inc.同比增速更快（24.5% vs 2.0%），MACOM Technology Solutions Holdings, Inc.自由现金流更多（$30.0M vs $16.8M），过去两年MACOM Technology Solutions Holdings, Inc.的营收复合增速更高（22.4% vs 8.0%）
MACOM是美国知名的射频、微波及毫米波半导体器件与组件研发生产商，总部位于马萨诸塞州洛厄尔，2005年曾是当地规模最大的私营雇主。公司已通过ISO9001国际质量体系认证及ISO14001环境管理体系认证，在北美、欧洲、亚洲及澳大利亚均设有设计中心与销售办事处。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MTSI vs OFIX — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $271.6M | $219.9M |
| 净利润 | $48.8M | $-2.2M |
| 毛利率 | 55.9% | 71.1% |
| 营业利润率 | 15.9% | 0.2% |
| 净利率 | 18.0% | -1.0% |
| 营收同比 | 24.5% | 2.0% |
| 净利润同比 | 129.1% | 92.4% |
| 每股收益（稀释后） | $0.64 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $271.6M | — | ||
| Q4 25 | $261.2M | $219.9M | ||
| Q3 25 | $252.1M | $205.6M | ||
| Q2 25 | $235.9M | $203.1M | ||
| Q1 25 | $218.1M | $193.6M | ||
| Q4 24 | — | $215.7M | ||
| Q3 24 | $200.7M | $196.6M | ||
| Q2 24 | $190.5M | $198.6M |
| Q1 26 | $48.8M | — | ||
| Q4 25 | $45.1M | $-2.2M | ||
| Q3 25 | $36.5M | $-22.8M | ||
| Q2 25 | $31.7M | $-14.1M | ||
| Q1 25 | $-167.5M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $29.4M | $-27.4M | ||
| Q2 24 | $19.9M | $-33.4M |
| Q1 26 | 55.9% | — | ||
| Q4 25 | 54.5% | 71.1% | ||
| Q3 25 | 55.3% | 72.2% | ||
| Q2 25 | 55.2% | 68.7% | ||
| Q1 25 | 53.7% | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | 54.7% | 68.7% | ||
| Q2 24 | 53.2% | 67.8% |
| Q1 26 | 15.9% | — | ||
| Q4 25 | 15.2% | 0.2% | ||
| Q3 25 | 14.9% | -8.3% | ||
| Q2 25 | 14.8% | -7.9% | ||
| Q1 25 | 8.0% | -25.2% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 13.7% | -9.6% | ||
| Q2 24 | 10.4% | -12.5% |
| Q1 26 | 18.0% | — | ||
| Q4 25 | 17.3% | -1.0% | ||
| Q3 25 | 14.5% | -11.1% | ||
| Q2 25 | 13.4% | -6.9% | ||
| Q1 25 | -76.8% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | 14.7% | -13.9% | ||
| Q2 24 | 10.5% | -16.8% |
| Q1 26 | $0.64 | — | ||
| Q4 25 | $0.67 | $-0.05 | ||
| Q3 25 | $0.48 | $-0.57 | ||
| Q2 25 | $0.42 | $-0.36 | ||
| Q1 25 | $-2.30 | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | $0.40 | $-0.71 | ||
| Q2 24 | $0.27 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $768.5M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $450.0M |
| 总资产 | $2.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $768.5M | — | ||
| Q4 25 | $786.0M | $82.0M | ||
| Q3 25 | $735.2M | $62.9M | ||
| Q2 25 | $681.5M | $65.6M | ||
| Q1 25 | $656.5M | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | $581.9M | $30.1M | ||
| Q2 24 | $521.5M | $26.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M |
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.3B | $450.0M | ||
| Q3 25 | $1.3B | $442.5M | ||
| Q2 25 | $1.2B | $458.3M | ||
| Q1 25 | $1.2B | $458.3M | ||
| Q4 24 | — | $503.1M | ||
| Q3 24 | $1.1B | $525.9M | ||
| Q2 24 | $1.1B | $546.0M |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $850.6M | ||
| Q3 25 | $2.0B | $832.6M | ||
| Q2 25 | $1.9B | $837.2M | ||
| Q1 25 | $1.8B | $823.1M | ||
| Q4 24 | — | $893.3M | ||
| Q3 24 | $1.8B | $867.9M | ||
| Q2 24 | $1.7B | $882.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $30.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 11.0% | 7.6% |
| 资本支出强度资本支出/营收 | 4.8% | 4.9% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $161.5M | $-1.3M |
8季度趋势，按日历期对齐
| Q1 26 | $42.9M | — | ||
| Q4 25 | $69.6M | $27.7M | ||
| Q3 25 | $60.4M | $12.4M | ||
| Q2 25 | $38.7M | $11.6M | ||
| Q1 25 | $66.7M | $-18.4M | ||
| Q4 24 | — | $23.7M | ||
| Q3 24 | $62.3M | $11.7M | ||
| Q2 24 | $49.0M | $9.0M |
| Q1 26 | $30.0M | — | ||
| Q4 25 | $49.4M | $16.8M | ||
| Q3 25 | $51.6M | $2.5M | ||
| Q2 25 | $30.5M | $4.5M | ||
| Q1 25 | $61.3M | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $57.1M | $6.3M | ||
| Q2 24 | $41.5M | $-360.0K |
| Q1 26 | 11.0% | — | ||
| Q4 25 | 18.9% | 7.6% | ||
| Q3 25 | 20.5% | 1.2% | ||
| Q2 25 | 12.9% | 2.2% | ||
| Q1 25 | 28.1% | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | 28.5% | 3.2% | ||
| Q2 24 | 21.8% | -0.2% |
| Q1 26 | 4.8% | — | ||
| Q4 25 | 7.7% | 4.9% | ||
| Q3 25 | 3.5% | 4.8% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 2.4% | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | 2.6% | 2.7% | ||
| Q2 24 | 3.9% | 4.7% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.54× | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.12× | — | ||
| Q2 24 | 2.46× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTSI
| Industrial Defense | $117.7M | 43% |
| Data Center | $85.8M | 32% |
| Telecom | $68.1M | 25% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
